Author

Seyede Atefe Hosseini

Observed names: Seyede A. Hosseini, SeyedeAtefe Hosseini
ORCID: 0000-0002-0384-9195
Observed ORCID: 0000-0002-0384-9195
OpenAlex ID: A5045390400
2020 · Fatemeh Zahedipour, Seyede Atefe Hosseini, et al. · Phytotherapy Research · 331
2025 · Seyede Atefe Hosseini, Somaye Noruzi, et al. · International Journal of Biological Macromolecules · 78
2019 · Mohammad Hossein Pourhanifeh, Rezvan Mohammadi, et al. · Cancer Cell International · 66
2021 · Amirhossein Sahebkar, Fatemeh Zahedipour, et al. · Neural Regeneration Research · 64
2021 · Seyede Atefe Hosseini, Fatemeh Zahedipour, et al. · BioFactors · 63
2023 · Farzad Kermani, Simin Nazarnezhad, et al. · International Journal of Molecular Sciences · 48
2022 · Seyede Atefe Hosseini, Seyed Javad Hoseini, et al. · Journal of Drug Delivery Science and Technology · 35
2018 · AmirReza Hesari, Mitra Azizian, et al. · Journal of Cellular Biochemistry · 34
2018 · Seyede Atefe Hosseini, Rezvan Mohammadi, et al. · Journal of Cellular Biochemistry · 33
2021 · Fatemeh Fotouhi, Mostafa Salehi-Vaziri, et al. · Microbes and Infection · 30
2018 · Somaye Noruzi, Mitra Azizian, et al. · Journal of Cellular Biochemistry · 28
2021 · Seyede Atefe Hosseini, Fatemeh Zahedipour, et al. · International Immunopharmacology · 27
2022 · Simin Nazarnezhad, Farzad Kermani, et al. · Journal of Pharmaceutical Sciences · 23
2022 · Shahrzad Ashouri, Seyede Atefe Hosseini, et al. · Tissue and Cell · 19
2023 · Zoleikha Azari, Sara Gorgani, et al. · Current Opinion in Biomedical Engineering · 14
2023 · Fatemeh Zahedipour, Seyede Atefe Hosseini, et al. · Critical Reviews in Oncology/Hematology · 12
2023 · Fatemeh Zahedipour, Seyede Atefe Hosseini, et al. · Current Medicinal Chemistry · 12
2023 · Sara Gorgani, Seyede Atefe Hosseini, et al. · Materials · 6
2021 · Amirhossein Sahebkar, Rezvan Mohammadi, et al. · Anti-Cancer Agents in Medicinal Chemistry · 5
2023 · Seyede Atefe Hosseini, Shahrzad Ashouri, et al. · Materials Letters · 3
Works count: 38
Citation count: 1,041
H-index: 18
I10-index: 21
Year
Topic
Type